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Background: Patients with established cardiovascular (CV) disease (CVD) are heterogeneous yet guidelines place them at the same high 
risk of a future CV event. They may have CV risk (CVR) assessment in primary care a time distant to their index CV event & it is uncertain 
how current CVR tools apply. We developed CVR models for patients with established CVD.
methods: Patients with prior CVD were selected from a New Zealand CVR management database (PREDICT) with linkage to national 
mortality, hospitalisation, dispensing and laboratory data. Cox models with all clinically relevant predictors and outcome of MI, stroke or CV 
death within 2yrs were developed. Model performance was assessed (bootstrapping).
results: 24,927 patients, 63% men, 63% European, mean age 65yrs, with 1,480 CV events in 2yrs. Age, Indian/Maori/Pacific ethnicity, 
prior MI/stroke, heart failure, diabetes, smoking, underweight, blood pressure (BP) <100 or ≥160mmHg, cholesterol ratio & creatinine 
significantly increased CVR. Obesity & East Asian ethnicity lowered CVR. Gender, family history, glucose, urate, white cell count, 
hemoglobin, statin, warfarin & BP lowering medication were not significant. Median 2yr absolute CVR was 5.2% (IQR 3.6-8.7%), with very 
good calibration (figure) and c-statistic 0.73 (IQR 0.72-0.73).
Conclusion:  A new equation has been developed to improve CVR stratification for patients with CVD in the community. Such models are 
required for risk stratification over the lifecourse of CVR & disease. 
